NCT05412654 is a NA clinical trial of High potassium water in Prehypertension, sponsored by Oxford Brookes University.

Who is sponsoring NCT05412654?

NCT05412654 is sponsored by Oxford Brookes University.

What drugs are being tested in NCT05412654?

Interventions in NCT05412654: High potassium water, Control low potassium water.

What condition does NCT05412654 study?

NCT05412654 studies Prehypertension.

Is NCT05412654 still recruiting?

NCT05412654 is currently completed. Last updated 4 April 2024.

Last reviewed 2024-04-04 · How we verify

NCT05412654

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Potassium Supplementation to Reduce Blood Pressure

Completed NA Last updated 4 April 2024

What this trial tests

NA trial testing High potassium water in Prehypertension in 40 participants. Completed in 1 December 2023.

Timeline

30 July 2022

Primary endpoint
1 December 2023

1 December 2023

Quick facts

Lead sponsor	Oxford Brookes University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	40
Start date	30 July 2022
Primary completion	1 December 2023
Estimated completion	1 December 2023
Sites	1 location across United Kingdom

Drugs / interventions tested

High potassium water
Control low potassium water

Conditions studied

Prehypertension — all drugs for Prehypertension →

Sponsor

Oxford Brookes University

Who can join

Adults 20 to 64, any sex, with Prehypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to conduct a definitive trial to assess the efficacy of consuming 1L/day of water rich in potassium to reduce blood pressure in mild to moderately hypertensive adults. The objective is to assess the potential effect of the intervention on reducing systolic blood pressure. This study will comprise of a 4 week, double-blind, parallel randomised controlled trial. Participants will be adults with systolic blood pressure measurements of 130mmHg or greater. The intervention comprises advice to consume bottled water rich in potassium. The comparator will be regular bottled mineral water.This study will recruit 40 people with elevated systolic blood pressure (≥130mmHg) who are not regularly taking antihypertensive medication.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Prehypertension

Currently open trials in the same condition.

NCT07372729 — Smartwatch-based Intervention for Cardiovascular Health (SWITCH) · NA · recruiting
NCT06762262 — Effects of Pilate Training Versus Moderate Intensity Continous Training in Hypertensive Patients · NA · active not recruiting
NCT05469503 — Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure · NA · active not recruiting
NCT06595251 — Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study · recruiting
NCT06596265 — Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study · recruiting

Other Oxford Brookes University trials

Trials by the same sponsor.

NCT06159296 — Effect of Inhaled Hydroxy Gas on Long COVID Symptoms · NA · unknown
NCT05888584 — Improving Access and Recruitment to Clinical Trials for Lung Cancer Patients · NA · recruiting
NCT05780164 — Improving Access to Lung Cancer Clinical Trials · recruiting
NCT05839860 — Salt Intake, Hydration Status and Gastrointestinal Discomfort During Fasting · NA · completed
NCT05286606 — Smart Community Rehabilitation · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05412654 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Oxford Brookes University
Last refreshed: 4 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05412654.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing